Constrained compounds as cgrp-receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/55 (2006.01) A61P 25/06 (2006.01) C07D 519/00 (2006.01)

Patent

CA 2651033

The invention encompasses constrained bicyclic and tricyclic CGRP-receptor antagonists, methods for identifying them, pharmaceutical compositions comprising them, and methods for their use in therapy for treatment of migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors. Formule I and II

L'invention concerne des antagonistes du récepteur du CGRP bicycliques et tricycliques à conformation limitée ; elle concerne également des procédés permettant d'identifier lesdits antagonistes, des compositions pharmaceutiques les comprenant et des procédés les utilisant dans le cadre d'un traitement contre la migraine et autres maux de tête, la vasodilatation neurogène, l'inflammation neurogène, les lésions thermiques, le choc circulatoire, les bouffées de chaleur associées à la ménopause, les maladies inflammatoires des voies respiratoires telles que l'asthme et la broncho-pneumopathie chronique obstructive (BPCO), et autres troubles pouvant être traités par action antagoniste sur les récepteurs du CGRP.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Constrained compounds as cgrp-receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Constrained compounds as cgrp-receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Constrained compounds as cgrp-receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1412866

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.